Books CANCER

Tracing a Translocation's Impact

See allHide authors and affiliations

Science  21 Jun 2013:
Vol. 340, Issue 6139, pp. 1407-1408
DOI: 10.1126/science.1240366

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Summary

Wapner's narrative follows developments from the recognition of a chromosomal abnormality in cancer cells to the production of a targeted drug against what had been a lethal leukemia.